- Could tofacitinib, the first oral small-molecule inhibitor proven for use in active rheumatoid arthritis (RA) patients with insufficient response to methotrexate, be the breakthrough drug for RA?
-
Kwok SK
- KMID: 1794621
- Korean J Intern Med.
- 2014 Sep;29(5):577-579.
- doi: 10.3904/kjim.2014.29.5.577
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Proper time to initiate antiosteoporotic treatment in rheumatoid arthritis with or without glucocorticoid use
-
Lee SW
- KMID: 2070106
- Korean J Intern Med.
- 2014 Jul;29(4):434-436.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Can We Calculate Patients' Compliance and Forecast Their Adherence to Medication: Cultural Adaptation of the Korean Version of a Compliance Questionnaire for Patients with Rheumatoid Arthritis
-
Ju JH
- KMID: 1036146
- Korean J Intern Med.
- 2011 Mar;26(1):25-27.
- doi: 10.3904/kjim.2011.26.1.25
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Description of the Efficacy and Safety of Three New Biologics in the Treatment of Rheumatoid Arthritis
-
Storage SS, Agrawal H, Furst DE
- KMID: 1785648
- Korean J Intern Med.
- 2010 Mar;25(1):1-17.
- doi: 10.3904/kjim.2010.25.1.1
English articles on abatacept, golimumab, and tocilizumab in rheumatoid arthritis published between 2002 and 2009 were reviewed systematically. All randomized clinical trials, open-label extensions, meta-analyses, and reviews were examined. There... -
- CITED
-
- Close
- SHARE
-
- Close
- Autologous Stem Cell Transplantation in the Treatment of Refractory Rheumatoid Arthritis
-
Kim KC, Lee IH, Choi JH, Oh MR, Ahn MJ, Kim SY
- KMID: 2157608
- J Korean Med Sci.
- 2002 Feb;17(1):129-132.
- doi: 10.3346/jkms.2002.17.1.129
The concept of using high-dose immunosuppressive treatment (HDIT) with autologous stem cell transplantation (ASCT) to treat patients with refractory rheumatoid arthritis has been provided by animal studies and anecdotal case... -
- CITED
-
- Close
- SHARE
-
- Close
- Etanercept-Induced Systemic Lupus Erythematosus in a Patient with Rheumatoid Arthritis
-
Kang MJ, Lee YH, Lee J
- KMID: 1781922
- J Korean Med Sci.
- 2006 Oct;21(5):946-949.
- doi: 10.3346/jkms.2006.21.5.946
Tumor necrosis factor (TNF) is known to play a critical role in the pathogenesis of rheumatoid arthritis (RA). Etanercept is a recombinant soluble fusion protein of TNF type II receptor... -
- CITED
-
- Close
- SHARE
-
- Close
- Adenoviral Pneumonia During Etanercept Treatment in a Patient with Rheumatoid Arthritis
-
Kang MJ, Kim MS, Choi EH, Lee KE, Kim YK, Choi HJ
- KMID: 1717999
- Korean J Intern Med.
- 2007 Mar;22(1):63-66.
- doi: 10.3904/kjim.2007.22.1.63
Inhibitors of tumor necrosis factor-alpha (TNF-alpha) have been approved for treating rheumatoid arthritis. As one of the biological response modifiers, etanercept has also been used in the treatment of psoriatic... -
- CITED
-
- Close
- SHARE
-
- Close
- Utilization Patterns of Disease-Modifying Antirheumatic Drugs in Elderly Rheumatoid Arthritis Patients
-
Jin XM, Lee J, Choi NK, Seong JM, Shin JY, Kim YJ, Kim MS, Yang BR, Park BJ
- KMID: 1789977
- J Korean Med Sci.
- 2014 Feb;29(2):210-216.
- doi: 10.3346/jkms.2014.29.2.210
This study was conducted to investigate disease-modifying antirheumatic drug (DMARD) utilization in Korean elderly patients with rheumatoid arthritis (RA). We used data from January 1, 2005 to June 30, 2006... -
- CITED
-
- Close
- SHARE
-
- Close
- Drug Survival Rates of Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis
-
Kang JH, Park DJ, Lee JW, Lee KE, Wen L, Kim TJ, Park YW, Lee SS
- KMID: 1794597
- J Korean Med Sci.
- 2014 Sep;29(9):1205-1211.
- doi: 10.3346/jkms.2014.29.9.1205
We investigated the compliance of Korean patients using tumor necrosis factor (TNF) inhibitors to treat rheumatoid arthritis (RA) and ankylosing spondylitis (AS), and identified potential predictors associated with treatment discontinuation.... -
- CITED
-
- Close
- SHARE
-
- Close
- Safe Re-administration of Tumor Necrosis Factor-alpha (TNFalpha) Inhibitors in Patients with Rheumatoid Arthritis or Ankylosing Spondylitis Who Developed Active Tuberculosis on Previous Anti-TNFalpha Therapy
-
Suh YS, Kwok SK, Ju JH, Park KS, Park SH, Yoon CH
- KMID: 1796912
- J Korean Med Sci.
- 2014 Jan;29(1):38-42.
- doi: 10.3346/jkms.2014.29.1.38
There is no consensus on whether it is safe to re-administer tumor necrosis factor-alpha (TNFalpha) inhibitors in patients with rheumatoid arthritis (RA) or ankylosing spondylitis (AS) flared after withdrawal of... -
- CITED
-
- Close
- SHARE
-
- Close
- Cultural Adaptation of a Compliance Questionnaire for Patients with Rheumatoid Arthritis to a Korean Version
-
Lee JY, Lee SY, Hahn HJ, Son IJ, Hahn SG, Lee EB
- KMID: 1036147
- Korean J Intern Med.
- 2011 Mar;26(1):28-33.
- doi: 10.3904/kjim.2011.26.1.28
BACKGROUND/AIMS: The Compliance Questionnaire-Rheumatology (CQR) is a validated scale to evaluate patient compliance for anti-rheumatic medications. We developed a Korean version of the CQR (KCQR) and confirmed its reliability and... -
- CITED
-
- Close
- SHARE
-
- Close
- A Clinical Trial and Extension Study of Infliximab in Korean Patients with Active Rheumatoid Arthritis despite Methotrexate Treatment
-
Kim J, Ryu H, Yoo DH, Park SH, Song GG, Park W, Cho CS, Song YW
- KMID: 1779410
- J Korean Med Sci.
- 2013 Dec;28(12):1716-1722.
- doi: 10.3346/jkms.2013.28.12.1716
Currently, infliximab is given for disease control for active rheumatoid arthritis (RA) patients despite methotrexate treatment. However, the efficacy and safety of infliximab in Korean patients has not been assessed... -
- CITED
-
- Close
- SHARE
-
- Close
- Tofacitinib Prevents Radiographic Progression in Rheumatoid Arthritis
-
Kim JW, Choi IA, Lee EY, Song YW, Lee EB
- KMID: 1793016
- J Korean Med Sci.
- 2013 Aug;28(8):1134-1138.
- doi: 10.3346/jkms.2013.28.8.1134
Tofacitinib, a novel Janus kinase inhibitor, may prevent structural damage in rheumatoid arthritis (RA). In this cohort study, we compared radiographic progression of hand joints between 21 RA patients who... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and safety of tofacitinib for active rheumatoid arthritis with an inadequate response to methotrexate or disease-modifying antirheumatic drugs: a meta-analysis of randomized controlled trials
-
Song GG, Bae SC, Lee YH
- KMID: 1794631
- Korean J Intern Med.
- 2014 Sep;29(5):656-663.
- doi: 10.3904/kjim.2014.29.5.656
BACKGROUND/AIMS: The aim of this study was to assess the efficacy and safety of tofacitinib (5 and 10 mg twice daily) in patients with active rheumatoid arthritis (RA). METHODS: A systematic... -
- CITED
-
- Close
- SHARE
-
- Close
